Shane William Charles Kovacs - 12 Jan 2024 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CH. OPERATING & FINANCIAL OFF.
Signature: /s/ Shane Kovacs
Issuer symbol: OLMA
Transactions as of: 12 Jan 2024
Net transactions value: +$351,000
Form type: 4
Filing time: 16 Jan 2024, 07:30:07 UTC
Previous filing: 12 Dec 2023
Next filing: 05 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$351,000	+50,000	+11%	$7.02	484,987	12 Jan 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-50,000	-21%	$0.000000	187,000	12 Jan 2024	Common Stock	50,000	$7.02	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.